THE ROLE OF SOLUBLE PROGRAMMED CELL DEATH PROTEIN 1 ON HBV RELAPSE AND HBsAg LOSS AFTER CESSATION OF ENTECAVIR THERAPY IN HBEAG-POSITIVE AND HBEAG-NEGATIVE NON-CIRRHOTIC PATIENTS

Chien Hung Chen, Jing-Houng Wang, Tsung-Hui Hu, Chao-Hung Hung, Sheng-Nan Lu

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalHepatology
Volume70
StatePublished - 2019

Cite this